Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Tyrosine Kinase

Items 31-40 of 351

Page
per page
  1. Methyl 2,5-dihydroxycinnamate
    B6358 Methyl 2,5-dihydroxycinnamate
    Summary: EGF receptor-associated tyrosine kinases inhibitor
      Soluble in ethanol
  2. SU 4312
    B6746 SU 4312
    Summary: VEGFR and PDGFR tyrosine kinases inhibitor
      insoluble in H2O; insoluble in EtOH; ≥9.45 mg/mL
  3. BFH772
    B6199 BFH772
    Summary: VEGFR2 inhibitor
      ≥53.4 mg/mL
  4. AG 99
    B6323 AG 99
    Summary: EGFR inhibitor
      Soluble in DMSO
  5. Dovitinib (TKI258) Lactate
    B5953 Dovitinib (TKI258) Lactate
    Target: CSF-1R|FLT3|VEGFR|PDGFR|c-Kit|FGFR
    Summary: Oral tyrosine kinase inhibitor (TKI) against FGFR1–3, VEGFR1–3, and platelet-derived growth factor receptor (PDGFR).
      insoluble in EtOH; ≥10.62 mg/mL
  6. Fruquintinib(HMPL-013)
    B5864 Fruquintinib(HMPL-013)
    Target: VEGFR
    Summary: Potent and selective inhibitor of VEGFR 1, 2, 3
      insoluble in H2O; insoluble in EtOH; ≥6.35 mg/mL
  7. CL-387785 (EKI-785)
    B5899 CL-387785 (EKI-785)
    Summary: Irreversible inhibiter of EGFR
      insoluble in EtOH; insoluble in H2O; ≥16.85 mg/mL
  8. AZD2932
    B5835 AZD2932
    Target: FLT3|VEGFR|PDGFR|c-Kit
    Summary: inhibitor of VEGFR-2, PDGFRβ, Flt-3, and c-Kit
      Soluble in DMSO
  9. EGF816
    B5889 EGF816
     2 Citation
    Target: EGFR
    Summary: Novel covalent inhibitor of mutant-selective EGFR
      Soluble in DMSO
  10. DMH4
    B5611 DMH4
     1 Citation
    Summary: VEGFR-2 inhibitor
      <20.02 mg/mL

Items 31-40 of 351

Page
per page